Ep2 receptor agonists for treating glaucoma

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/71 (2006.01) A61K 31/4406 (2006.01) A61P 9/12 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2602442

The present invention provides novel compounds represented by the formula wherein R is as defined in the specification and wherein said compounds are useful for treating ocular hypertension and/or providing neuroprotection to the eye of a mammal.

L'invention porte sur de nouveaux composés de formule (I) dans laquelle: R est tel que défini dans les spécifications, lesdits composés s'avérant utiles pour traiter l'hypertension oculaire et/ou assurer la neuroprotection de l'oeil chez les mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ep2 receptor agonists for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ep2 receptor agonists for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ep2 receptor agonists for treating glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1528773

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.